Covered recipient · General Payments record
DENNIS W OZMENT
Allopathic & Osteopathic Physicians Internal Medicine Rheumatology
General Payments · PY2018–2024
$3,689.35
- Reported across 251 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $316.87 | 17 |
| Education | $29.60 | 2 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $266.33 | 15 |
| E.R. Squibb & Sons, L.L.C. | $29.60 | 2 |
| ABBVIE INC. | $28.32 | 1 |
| Acerta Pharma LLC | $22.22 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $28.32 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105166273 | CMS |
| Amgen Inc. | $26.73 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111667610 | CMS |
| Amgen Inc. | $18.76 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111667594 | CMS |
| Amgen Inc. | $13.12 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111667596 | CMS |
| Amgen Inc. | $8.70 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111667612 | CMS |
| Amgen Inc. | $20.91 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111667598 | CMS |
| Amgen Inc. | $13.02 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111667600 | CMS |
| Amgen Inc. | $24.80 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111667602 | CMS |
| Amgen Inc. | $16.23 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111667614 | CMS |
| Amgen Inc. | $14.68 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111667616 | CMS |
| Amgen Inc. | $12.72 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111667604 | CMS |
| Amgen Inc. | $24.60 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111667620 | CMS |
| Amgen Inc. | $17.75 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111667618 | CMS |
| Amgen Inc. | $15.22 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117345130 | CMS |
| Amgen Inc. | $10.27 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111667606 | CMS |
| Amgen Inc. | $28.82 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111667608 | CMS |
| AstraZeneca Pharmaceuticals LP | $22.22 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105757101 | CMS |
| E.R. Squibb & Sons, L.L.C. | $14.80 | 01/25/2024 | Education | Undisputed | 01/23/2026 | 1101810802 | CMS |
| E.R. Squibb & Sons, L.L.C. | $14.80 | 02/26/2024 | Education | Undisputed | 01/23/2026 | 1101810810 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.